Trial Profile
Phase II Study of cisplatin plus irinotecan for large cell neuroendocrine carcinoma.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Cisplatin
- Indications Neuroendocrine carcinoma
- Focus Therapeutic Use
- 30 Dec 2010 New trial record